Filing Details
- Accession Number:
- 0001209191-13-010707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-21 21:15:34
- Reporting Period:
- 2013-02-21
- Filing Date:
- 2013-02-21
- Accepted Time:
- 2013-02-21 21:15:34
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434715 | A Charles Morreale | 901 Fifth Avenue, Suite 1000 Seattle WA 98164 | Vp Field Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-21 | 10,000 | $6.63 | 128,526 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-21 | 10,390 | $3.74 | 138,916 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-21 | 6,874 | $5.47 | 145,790 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-21 | 27,264 | $18.93 | 118,526 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-02-21 | 10,000 | $0.00 | 10,000 | $6.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-02-21 | 10,390 | $0.00 | 10,390 | $3.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-02-21 | 6,874 | $0.00 | 6,874 | $5.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2018-05-16 | No | 4 | M | Direct | |
| 12,579 | 2019-05-13 | No | 4 | M | Direct | |
| 13,126 | 2020-05-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,059 | Indirect | By 401(k) plan |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2011.
- The reported price in Column 4 is a weighted average exercise price. These shares were sold in multiple transactions at prices ranging from $18.80 to $19.06 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- This option was fully exerciseable on May 16, 2012.
- 25% vested on May 13, 2010 and 1/48th vests monthly thereafter, with the result that 100% of the grant amount shall vest and be exercisable on May 13, 2013.
- 25% vested on May 12, 2011 and 1/48th vests monthly thereafter, with the result that 100% of the grant amount shall vest and be exercisable on May 12, 2014.
Billionaire Hedge Funds
